SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
RAPP

Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · Real-Time Price · USD
Healthcare · Biotechnology
25.71-0.22 (-0.85%)
 
Market cap
$1.23B
Insider Score
Health Score
Analyst consensus
Insider Score
/ 100
RAPP Insider Score

Rapport Therapeutics, Inc. has a live Insider Score.

Scored on 6 qualifying trades from 5 insiders in the last 90 days.

Unlock the score

RAPP Stock Insider Trading Activity

RAPP stock’s insider trading shows 6 purchases for an estimated $1.52M and 22 sales on the open market for an estimated $7.02M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days6 qualifying buys5 insiders$1.52M bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Sanchez Ramiro
Director
Buy3,600$27.35$98.48K New3,600Oct 23, 2026BCluster BuyFirst BuyDilution Form 4
MARAGANORE JOHN
Director
Buy8,239$26.38$217.34K New8,239Oct 22, 2026ACluster BuyFirst BuyDilution Form 4
Young Wendy B.
Director
Buy3,789$26.39$99.99K 39.9%13,289Oct 22, 2026CCluster BuyFirst BuyDilution Form 4
PAUL STEVEN M
Director
Buy35,714$27.28$974.28K 85.7%77,380Oct 22, 2026ACluster BuyFirst BuyDilution Form 4
MARAGANORE JOHN
Director
Buy1,172$26.92$31.55K 14.2%9,411Oct 22, 2026CCluster BuyFirst BuyDilution Form 4
Silva Paul M
Director
Buy3,680$27.07$99.64K New3,680Oct 22, 2026BCluster BuyFirst BuyDilution Form 4
Ceesay Abraham
CEO
Sell2,210$29.16$64.45K 0.5%450,035Oct 21, 2026— Form 4
Ceesay Abraham
CEO
Sell1,147$30.66$35.17K 0.3%452,245Oct 7, 2026— Form 4
Ceesay Abraham
CEO
Sell3,375$32.03$108.11K 0.7%453,392Oct 6, 2026— Form 4
Gault Cheryl
COO
Sell2,075$33.76$70.04K 1.5%139,914Sep 30, 2026— Form 4
Gault Cheryl
COO
Sell7,925$33.04$261.81K 5.3%141,989Sep 30, 2026— Form 4
Ceesay Abraham
CEO
Sell215$39.86$8.57K 0.0%456,810Sep 23, 2026— Form 4
Ceesay Abraham
CEO
Sell1,952$39.05$76.23K 0.4%457,025Sep 23, 2026— Form 4
Ceesay Abraham
CEO
Sell43$41.05$1.77K 0.0%456,767Sep 23, 2026— Form 4
Ceesay Abraham
CEO
Sell1,069$46.01$49.19K 0.2%458,977Sep 8, 2026— Form 4
Ceesay Abraham
CEO
Sell7,141$45.55$325.31K 1.5%460,046Sep 8, 2026— Form 4
Yeleswaram Krishnaswamy
Other
Sell16,201$51.06$827.18K 7.6%195,862Aug 25, 2026— Form 4
Yeleswaram Krishnaswamy
Other
Sell20,799$50.31$1.05M 8.9%212,063Aug 25, 2026— Form 4
Ceesay Abraham
CEO
Sell18,921$49.57$937.96K 3.9%467,187Aug 25, 2026— Form 4
Yeleswaram Krishnaswamy
Other
Sell13,160$50.00$657.98K 5.3%232,862Aug 24, 2026— Form 4
Yeleswaram Krishnaswamy
Other
Sell404$49.90$20.16K 0.2%246,022Aug 19, 2026— Form 4
Ceesay Abraham
CEO
Sell3,664$46.90$171.84K 0.7%511,402Aug 11, 2026— Form 4
Ceesay Abraham
CEO
Sell19,500$48.04$936.85K 3.8%491,902Aug 11, 2026— Form 4
Ceesay Abraham
CEO
Sell5,794$48.62$281.72K 1.2%486,108Aug 11, 2026— Form 4
Ceesay Abraham
CEO
Sell14,171$45.97$651.49K 2.6%523,436Aug 10, 2026— Form 4
Ceesay Abraham
CEO
Sell8,370$46.75$391.28K 1.6%515,066Aug 10, 2026— Form 4
Ceesay Abraham
CEO
Sell2,203$42.11$92.76K 0.4%537,614Jul 27, 2026— Form 4
Ceesay Abraham
CEO
Sell7$42.73$299.15 0.0%537,607Jul 27, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Buy (P) — Open-market or private purchase
  • Sell (S) — Open-market or private sale
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.